Two Houston-based companies made it into this new clean tech accelerator. Photo via greentownlabs.com

The Low-Carbon Hydrogen Accelerator announced its inaugural class of clean tech startups — two of which hail from right here in Hosuton.

In all, seven startups have been chosen to participate this year in the Low-Carbon Hydrogen Accelerator, which was announced in November. The six-month accelerator program offers collaboration and engagement opportunities with the Electric Power Research Institute and its member utilities, as well as with Shell. Through the accelerator, the institute and Shell will provide startups with two innovation paths: a technology validation track and a technology demonstration track.

The accelerator — part of the Green Go program, affiliated with Greentown Labs — is aimed at coming up with innovations in low-carbon hydrogen production, storage, and distribution.

“Accelerating low-carbon hydrogen technologies is an essential part of achieving global net-zero targets by 2050,” Neva Espinoza, vice president of energy supply and low-carbon resources at the Electric Power Research Institute, says in a news release.

The inaugural LCHA cohort includes:

  • Advanced Ionics, based in Milwaukee, is enabling green hydrogen production without the green premium.
  • Arco Technologies from Bologna, Italy, is developing a proprietary Anion Exchange Membrane electrolyzer with the lowest capital expenditures and operating expenses possible today.
  • Based in Manchester in the United Kingdom, Clean Power is developing a novel, low-cost, highly durable hydrogen polymer electrolyte membrane fuel cell delivering zero-emission electricity.
  • Element Resources, based in Houston, is enabling compressed hydrogen storage tank technology.
  • Another local company, Smartpipe Technologies is developing a robust self-monitored repurposed pipeline system for hydrogen with minimal environmental disruption.
  • SPEC Sensors from California is creating a robust and reliable meshed sensor network for hydrogen leak detection and line-monitoring systems.
  • Canadian company RUNWITHIT Synthetics is creating a live, digital twin modeling platform that generates decision-support data for regional hydrogen-demand scenarios.

Element Resources, which produces hydrogen from renewables for mobility, power production, and energy storage, is collaborating with Zhifeng Ren, M.D. Anderson chair professor in physics and director of the Texas Center for Superconductivity at the University of Houston.

The other Houston startup, Smartpipe Technologies, announced earlier this month that Canadian pipeline company Enbridge had made a $6.6 million investment in the startup.

For 2022, the accelerator received applications from 88 startups in 18 countries. The five other participants this year are from California; Wisconsin; Alberta, Canada; Italy; and the United Kingdom.

Aside from the Electric Power Research Institute, Shell USA, and Greentown, the accelerator’s partners are the City of Houston and the Urban Future Lab at New York University’s Tandon School of Engineering.

“Creating a robust hydrogen economy will require a systems-oriented approach and unparalleled cooperation between corporate partners and emerging companies,” says Ryan Dings, chief operating officer and general counsel at Greentown Labs.

Greentown operates startup incubators in Somerville, Massachusetts, and Houston.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.